Inspirion Delivery Sciences Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate Release Tablets with Abuse-Deterrent Label Claims

BASKING RIDGE, N.J., April 26, 2017 /PRNewswire/ -- Inspirion Delivery Sciences, LLC ( " Inspirion " ) announced that the United States Food and Drug Administration (FDA) has approved RoxyBond ™ (oxycodone hydrochloride) tablets, for oral use, CII,...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news